Latuda Tablet, Film Coated
Pricing Report NDC 63402-306-10

Latest NADAC: $39.11791 per EA · Effective Aug 21, 2019 · Est. package price $391.18 (10 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Latuda (NDC 63402-306-10) is $39.11791 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 21, 2019.

As a a human prescription drug provided by Sumitomo Pharma America, Inc., this medication is distributed in a 10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK (63402-306-01) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$39.11791
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 21, 2019
Billable Units
10 EA
Estimated Package Price
$391.18
Data Status
As of Dec 04, 2019
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
63402-306-10
Description
10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK (63402-306-01)
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2014, the NADAC wholesale price for (NDC ) has moved within a range of $21.43953 to $46.97461 per EA. Over this 12 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$21.4395 - $46.9746
Market Volatility
119.10% Variance
Latest Trend
0.08%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $46.80033 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $46.83579 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $46.97461 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 01, 2026 $46.78946 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2026 $46.78946 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2026 $46.78946 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 01, 2026 $46.78946 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 01, 2026 $46.78946 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 01, 2026 $46.78946 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2025 $45.42666 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $45.38740 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $45.35440 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026